The FMS-like tyrosine kinase 3 (FLT3) gene mutation is among the most prevalent genetic alterations in Acute myeloid leukemia (AML), occurring in approximately 30% of cases. This evidence concerns the gene FLT3 and acute myeloid leukemia.